ThermoGenesis
Rancho Cordova, CA
Platform Provider
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
57.8
Signal Score
○ FDA Inspections
✓ Clinical Trials (1)
○ SEC Filings
✓ Press (5)
○ EMA GMP
○ MHRA GMP
Quick Facts: ThermoGenesis
- Signal Score
- 57.8/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Rancho Cordova, CA
- Modalities
- Cell Therapy
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About ThermoGenesis
CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
60.0
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Source: ClinicalTrials.gov · Retrieved Oct 07, 2026
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
53.0
Profile-based capacity assessment
Recent Press5 articles
Clinical Activity 1 studies
NCT02538978
Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System
PHASE3
Unknown
Source: ClinicalTrials.gov · Retrieved Oct 07, 2026
Recent News 5 articles
ThermoGenesis Holdings stock (US88603Y1055): Is its cell therapy focus strong enough to unlock biote - AD HOC NEWS
ThermoGenesis Holdings stock (US88603Y1055): Is its cell therapy focus strong enough to unlock biote AD HOC NEWS
ThermoGenesis Holdings stock (US88603Y1055): Is its cell therapy focus strong enough to unlock biote - AD HOC NEWS
ThermoGenesis Holdings stock (US88603Y1055): Is its cell therapy focus strong enough to unlock biote AD HOC NEWS
ThermoGenesis Holdings Stock: Cell Therapy Leader with Growth Potential for North American Investors - AD HOC NEWS
ThermoGenesis Holdings Stock: Cell Therapy Leader with Growth Potential for North American Investors AD HOC NEWS
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth - AD HOC NEWS
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth ad-hoc-news.de
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth - ad-hoc-news.de
ThermoGenesis Holdings Stock: Pioneering Cell and Gene Therapy Tools Amid Biotech Sector Growth AD HOC NEWS
Frequently Asked Questions About ThermoGenesis
How many clinical programs is ThermoGenesis linked to?
ThermoGenesis is associated with 1 clinical trial in CDMO Signal's ClinicalTrials.gov-sourced data.
What is ThermoGenesis's CDMO Signal Score?
ThermoGenesis has a Signal Score of 58/100, based on quality, operations, financial stability, and capacity data.
Evaluating ThermoGenesis for a manufacturing program?
Use the free AI matchmaker to compare ThermoGenesis against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
City of Hope (T Cell Manufacturing)
Duarte, CA
Signal Score: 83.9
CAR-T, Cell Therapy
Eurofins CDMO
Planegg, DE · San Diego, CA
Signal Score: 81.6
Biologics, Cell Therapy
Bayer (Cell Therapy Mfg)
Berkeley, CA
Signal Score: 80.4
Cell Therapy, Gene Editing
Cedars-Sinai Biomanufacturing
Los Angeles, CA
Signal Score: 79.8
Cell Therapy, Gene Editing